5,6-dioxo-11-methoxy voacangine - Compound Card

5,6-dioxo-11-methoxy voacangine

Select a section from the left sidebar

5,6-dioxo-11-methoxy voacangine

Structure
Zoomed Structure
  • Family: Plantae - Apocynaceae
  • Kingdom: Plantae
  • Class: Alkaloid
    • Subclass: Indole Alkaloid
Canonical Smiles c1(c(cc2c(c1)c1c([nH]2)[C@]2([C@H]3N(C(=O)C1=O)C[C@H](C2)C[C@@H]3CC)C(=O)OC)OC)OC
InChI InChI=1S/C23H26N2O6/c1-5-12-6-11-9-23(22(28)31-4)19-17(18(26)21(27)25(10-11)20(12)23)13-7-15(29-2)16(30-3)8-14(13)24-19/h7-8,11-12,20,24H,5-6,9-10H2,1-4H3/t11-,12-,20-,23+/m0/s1
InChIKey PQXBOONHFLXCNI-NBUVOGKTSA-N
Formula C23H26N2O6
HBA 6
HBD 1
MW 426.47
Rotatable Bonds 4
TPSA 97.93
LogP 2.44
Number Rings 6
Number Aromatic Rings 2
Heavy Atom Count 31
Formal Charge 0
Fraction CSP3 0.52
Exact Mass 426.18
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Tabernaemontana contorta Apocynaceae Plantae 761060

Showing of synonyms

  • Foudjo Melacheu G, Mfotie Njoya E, et al. (2019). Two new indole alkaloids from Tabernaemontana contorta Stapf. Phytochemistry Letters, 2019, 30, 116-119. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: c1cccc2[nH]c(c3c12)C4C5N(C(=O)C3=O)CC(C4)CC5

Level: 0

Mol. Weight: 426.47 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-5.02
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.82
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Substrate
Skin Permeability
-1.1

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.76
Plasma Protein Binding
62.07
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Inhibitor
CYP 1A2 Substrate
Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
5.96
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Toxic
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-0.21
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Toxic
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
-0.84
Liver Injury II
Toxic
hERG Blockers
Safe
Daphnia Maga
5.66
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-84.3
Rat (Acute)
2.91
Rat (Chronic Oral)
2.47
Fathead Minnow
4.17
Respiratory Disease
Toxic
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Toxic
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Toxic

General Properties

Boiling Point
487.9
Hydration Free Energy
-2.62
Log(D) at pH=7.4
2.54
Log(P)
1.89
Log S
-4.52
Log(Vapor Pressure)
-8.64
Melting Point
289.39
pKa Acid
7.01
pKa Basic
5.11

No predicted protein targets found for this compound.

Download SDF